content: <PAGE>
  
  ================================================================================
  
  
  
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C.  20549
  
  
  
  
  
                                     FORM 8-K
  
  
  
  
                                  CURRENT REPORT
                        Pursuant to Section 13 or 15(d) of
                        The Securities Exchange Act of 1934
  
  
                          Date of Report: April 25, 2000
                         (Date of earliest event reported)
  
  
                                 drkoop.com, Inc.
              (exact name of registrant as specified in its charter)
  
  <TABLE>
  <S>                                          <C>                                   <C>
              Delaware                              Commission File:                              95-4697615
    (State or other jurisdiction                      000-26275                       (I.R.S. Employer Identification No.)
    of incorporation or organization)
  
  
  </TABLE>
  
                                 7000 North Mopac
                                Austin, Texas 78731
           (Address of Principal executive offices, including zip code)
  
  
  
                                  (512) 583-5667
               (Registrant's telephone number, including area code)
  
  
  
  
  ===============================================================================
  <PAGE>
  
  ITEM 5.  OTHER EVENTS.
  
       On April 25, 2000, our company, drkoop.com, Inc., a Delaware corporation
  (the "Company"), released two press releases, each of which is attached to this
  Report as Exhibits 5.1 and 5.2, respectively, and which are incorporated herein
  by this reference.  The incorporated press releases shall not be deemed to
  include any material in any of the hyperlinks to Internet sites included
  therein.
  
       Portal Renegotiations.  The consideration for the renegotiation of the
       ---------------------
  portal agreements referred to in the press releases consisted of, in the
  aggregate, (a) 3,500,000 shares of Company common stock; (b) cash payments to be
  made over the next six months, including accrued costs of service; and (c)
  warrants to acquire 820,000 shares of common stock at an exercise price of $1.25
  per share (subject to anti-dilution adjustment for specified future financings).
  In addition, the 775,000 warrants presently held by one of the portal partners
  became presently exercisable.  The cash payments to be made are included in the
  accounts payable disclosed in the press release attached as Exhibit 5.1.
  
       After giving effect to these transactions, the Company has outstanding as
  of the date of this Report: (i) approximately 34,683,000 shares of common stock,
  (ii) warrants to purchase approximately 1,628,000 shares of common stock at
  exercise prices of $1.25 to $8.60; and (iii) stock options to acquire
  approximately 11,584,000 shares of common stock, of which approximately
  5,622,000 are vested with exercise prices varying from $0.01 to $13.88.
  
       This Report includes forward-looking statements that are based on current
  expectations and involve risks and uncertainties. drkoop.com cannot guarantee
  that actual future events will not vary materially from those described in this
  Report.  Specifically, the sources and uses of cash resources, the nature and
  deployment of new products and services and the continued operations of the
  business are uncertain and cannot be assured.  In addition, our traffic growth
  is subject to our ability to continue to attract and retain our audience of
  users by providing healthcare content, tools and other features which meet the
  changing demands of those users. For a further discussion of the business risks
  faced by drkoop.com, please see the section captioned ``Risk Factors'' in our
  Form 10-K for the year ended December 31, 1999 filed with the Securities and
  Exchange Commission. drkoop.com undertakes no obligation to update any of the
  forward-looking statements in this Report.  In particular, no duty to update is
  undertaken with respect to projections of cash sources and uses.
  
  
  
                                   *  *  *  *  *
  
                                         2
  <PAGE>
  
  ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA INFORMATION AND EXHIBITS.
  
  (a)  Financial Statements of Business Acquired.
  
       Not applicable.
  
  (b)  Pro Forma Financial Information.
  
       Not applicable.
  
  (c)  Exhibits
  
       5.1  Press Release dated April 25, 2000 regarding corporate developments.
  
       5.2  Press Release dated April 25, 2000 regarding Go.com.
  
                                         3
  <PAGE>
  
                                     SIGNATURES
  
  
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized,
  
  
                                 drkoop.com, Inc.
  
  
  
  Date:  April 26, 2000          By  /S/  Susan M. Georgen-Saad
                                     --------------------------
                                    Name:    Susan M. Georgen-Saad
                                    Title:   Chief Financial Officer
  
                                         4
  <PAGE>
  
                                   EXHIBIT INDEX
  
  
  <TABLE>
  <CAPTION>
                                                                             Sequentially
  Exhibit                                                                     Numbered
    No.                                   Description                           Page
  -------                                 -----------                       ------------
  <S>                              <C>                                      <C>
  5.1                              Press Release dated April 25,
                                   2000 regarding corporate
                                   developments
  5.2                              Press Release dated April 25,
                                   2000 regarding Go.com
  </TABLE>
  
  
  
                                   *  *  *  *  *
metadata_documents: [{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 6012}]
metadata_filer: {"company-data": {"conformed-name": "DRKOOP COM INC", "cik": "0001073794", "assigned-sic": "8090", "irs-number": "954697615", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26275", "film-number": "610824"}, "business-address": {"street1": "8920 BUSINESS PARK DR", "street2": "C/O EMPOWER HEALTH CORP", "city": "AUSTIN", "state": "TX", "zip": "78759", "phone": "5127265110"}, "mail-address": {"street1": "EMPOWER HEALTH CORP", "street2": "8920 BUSINESS PARK DRIVE", "city": "AUSTIN", "state": "TX", "zip": "78759"}, "former-company": {"former-conformed-name": "EMPOWER HEALTH CORP", "date-changed": "19990224"}}
text: ================================================================================
  
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C.  20549
  
                                     FORM 8-K
  
                                  CURRENT REPORT
                        Pursuant to Section 13 or 15(d) of
                        The Securities Exchange Act of 1934
  
                          Date of Report: April 25, 2000
                         (Date of earliest event reported)
  
                                 drkoop.com, Inc.
              (exact name of registrant as specified in its charter)
  Delaware                              Commission File:                              95-4697615
    (State or other jurisdiction                      000-26275                       (I.R.S. Employer Identification No.)
    of incorporation or organization)
  7000 North Mopac
                                Austin, Texas 78731
           (Address of Principal executive offices, including zip code)
  
                                  (512) 583-5667
               (Registrant's telephone number, including area code)
  
  ===============================================================================
  ITEM 5.  OTHER EVENTS.
  
       On April 25, 2000, our company, drkoop.com, Inc., a Delaware corporation
  (the "Company"), released two press releases, each of which is attached to this
  Report as Exhibits 5.1 and 5.2, respectively, and which are incorporated herein
  by this reference.  The incorporated press releases shall not be deemed to
  include any material in any of the hyperlinks to Internet sites included
  therein.
  
       Portal Renegotiations.  The consideration for the renegotiation of the
       ---------------------
  portal agreements referred to in the press releases consisted of, in the
  aggregate, (a) 3,500,000 shares of Company common stock; (b) cash payments to be
  made over the next six months, including accrued costs of service; and (c)
  warrants to acquire 820,000 shares of common stock at an exercise price of $1.25
  per share (subject to anti-dilution adjustment for specified future financings).
  In addition, the 775,000 warrants presently held by one of the portal partners
  became presently exercisable.  The cash payments to be made are included in the
  accounts payable disclosed in the press release attached as Exhibit 5.1.
  
       After giving effect to these transactions, the Company has outstanding as
  of the date of this Report: (i) approximately 34,683,000 shares of common stock,
  (ii) warrants to purchase approximately 1,628,000 shares of common stock at
  exercise prices of $1.25 to $8.60; and (iii) stock options to acquire
  approximately 11,584,000 shares of common stock, of which approximately
  5,622,000 are vested with exercise prices varying from $0.01 to $13.88.
  
       This Report includes forward-looking statements that are based on current
  expectations and involve risks and uncertainties. drkoop.com cannot guarantee
  that actual future events will not vary materially from those described in this
  Report.  Specifically, the sources and uses of cash resources, the nature and
  deployment of new products and services and the continued operations of the
  business are uncertain and cannot be assured.  In addition, our traffic growth
  is subject to our ability to continue to attract and retain our audience of
  users by providing healthcare content, tools and other features which meet the
  changing demands of those users. For a further discussion of the business risks
  faced by drkoop.com, please see the section captioned ``Risk Factors'' in our
  Form 10-K for the year ended December 31, 1999 filed with the Securities and
  Exchange Commission. drkoop.com undertakes no obligation to update any of the
  forward-looking statements in this Report.  In particular, no duty to update is
  undertaken with respect to projections of cash sources and uses.
  
                                   *  *  *  *  *
  
                                         2
  ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA INFORMATION AND EXHIBITS.
  
  (a)  Financial Statements of Business Acquired.
  
       Not applicable.
  
  (b)  Pro Forma Financial Information.
  
       Not applicable.
  
  (c)  Exhibits
  
       5.1  Press Release dated April 25, 2000 regarding corporate developments.
  
       5.2  Press Release dated April 25, 2000 regarding Go.com.
  
                                         3
  SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized,
  
                                 drkoop.com, Inc.
  
  Date:  April 26, 2000          By  /S/  Susan M. Georgen-Saad
                                     --------------------------
                                    Name:    Susan M. Georgen-Saad
                                    Title:   Chief Financial Officer
  
                                         4
  EXHIBIT INDEX
  Sequentially
  Exhibit                                                                     Numbered
    No.                                   Description                           Page
  -------                                 -----------                       ------------
  5.1                              Press Release dated April 25,
                                   2000 regarding corporate
                                   developments
  5.2                              Press Release dated April 25,
                                   2000 regarding Go.com
  *  *  *  *  *